VTVT — vTv Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for vTv Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 13.4 | 12.1 | 9.45 | 36.7 | 88.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.057 | 12.4 | 0.102 | 0.062 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 15.6 | 27.1 | 10.7 | 38.1 | 89.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.68 | 0.556 | 0.361 | 0.153 | — |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 25.5 | 33.2 | 11 | 38.3 | 89.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.5 | 7.71 | 10.6 | 5.2 | 6.64 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 35.2 | 44 | 35.7 | 26.1 | 25.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -9.74 | -10.7 | -24.7 | 12.2 | 64.4 |
| Total Liabilities & Shareholders' Equity | 25.5 | 33.2 | 11 | 38.3 | 89.9 |
| Total Common Shares Outstanding |